PMID- 36737757
OWN - NLM
STAT- MEDLINE
DCOM- 20230207
LR  - 20230221
IS  - 1471-244X (Electronic)
IS  - 1471-244X (Linking)
VI  - 23
IP  - 1
DP  - 2023 Feb 3
TI  - Cognitive behavior therapy for diabetes distress, depression, health anxiety, 
      quality of life and treatment adherence among patients with type-II diabetes 
      mellitus: a randomized control trial.
PG  - 86
LID - 10.1186/s12888-023-04546-w [doi]
LID - 86
AB  - OBJECTIVE: Diabetes distress typically causes depressive symptoms; common 
      comorbidity of diabetes unpleasantly affects patients' medical and psychological 
      functions. Psychotherapeutic interventions are effective treatments to treat 
      depressive symptoms and to improve the quality of life in many chronic diseases 
      including diabetes. The present study investigated the efficacy of cognitive 
      behavior therapy (CBT) to treat depressive symptoms in patients with type 2 
      diabetes mellitus (T2DM) using experimental and waitlist control conditions. 
      MATERIALS AND METHODS: A total of 130 diagnosed patients with T2DM were taken 
      from outdoor patients services of different hospitals in Faisalabad. Ninety 
      patients met the eligibility criteria and were randomly assigned to experimental 
      (n = 45) and waitlist control (n = 45) conditions. All the patients completed 
      clinical interviews and assessment measures at pre-and post-assessment stages 
      (16 weeks intervals). Medical consultants at the respective hospitals diagnosed 
      the patients on the base of their medical reports and then referred those 
      patients to us. Then we used different scales to assess primary and secondary 
      outcomes: Diabetes Distress Scale (DDS) and Patient Health Questionnaire (PHQ) to 
      assess primary outcomes, and a Short Health Anxiety Inventory (SHAI), a Revised 
      Version of the Diabetes Quality of Life Questionnaire (DQLQ), and a General 
      Medication Adherence Scale (GMAS) were used to investigate secondary outcomes. 
      Repeated measure ANOVA was used to analyze the results. RESULTS: The findings 
      indicated that patients who received CBT got a significant reduction in their 
      diabetes distress F(1,60) = 222.710, P < 0.001, eta(2) = .788), depressive symptoms 
      F(1,60) = 94.436, P < 0.001, eta(2) = .611), health anxiety F(1,60) = 201.915, 
      P < .0.001, eta(2) = 771), and a significant improvement in their quality of life 
      F(1,60) = 83.352, P < 0.001, eta(2) = .581), treatment adherence F(1,60) = 67.579, 
      P < 0.001, eta(2) = .566) and physical activity schedule F(1,60) = 164.245, 
      P < .0.001, eta(2) = .736 as compared to the patients in waitlist control 
      condition. CONCLUSION: It is concluded that cognitive behavior therapy is an 
      effective and promising intervention for depressive symptoms, diabetes distress, 
      and health anxiety which also helps the person to promote quality of life, 
      treatment adherence and physical activity.
CI  - (c) 2023. The Author(s).
FAU - Abbas, Qasir
AU  - Abbas Q
AD  - Department of Applied Psychology, Government College University Faisalabad, Old 
      Campus, Faisalabad, Pakistan. qasirabbas47@yahoo.com.
FAU - Latif, Sana
AU  - Latif S
AD  - Department of Applied Psychology, Government College University Faisalabad, Old 
      Campus, Faisalabad, Pakistan.
FAU - Ayaz Habib, Hina
AU  - Ayaz Habib H
AD  - Institute of Clinical Psychology, University of Karachi, Karachi, Pakistan.
FAU - Shahzad, Salman
AU  - Shahzad S
AD  - Institute of Clinical Psychology, University of Karachi, Karachi, Pakistan.
FAU - Sarwar, Uzma
AU  - Sarwar U
AD  - Department of Psychology, Government College Women University Sialkot, Sialkot, 
      Pakistan.
FAU - Shahzadi, Mafia
AU  - Shahzadi M
AD  - Department of Applied Psychology, Government College University Faisalabad, Main 
      Campus, Faisalabad, Pakistan.
FAU - Ramzan, Zoobia
AU  - Ramzan Z
AD  - Institute of Behavioral Sciences, Dow University of Health Sciences, Karachi, 
      Pakistan.
FAU - Washdev, Washdev
AU  - Washdev W
AD  - Institute of Behavioral Sciences, Dow University of Health Sciences, Karachi, 
      Pakistan.
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20230203
PL  - England
TA  - BMC Psychiatry
JT  - BMC psychiatry
JID - 100968559
SB  - IM
MH  - Humans
MH  - *Diabetes Mellitus, Type 2/complications/therapy/psychology
MH  - Depression/complications/therapy
MH  - Quality of Life
MH  - *Cognitive Behavioral Therapy/methods
MH  - Anxiety/complications/therapy
MH  - Treatment Outcome
MH  - Treatment Adherence and Compliance
PMC - PMC9896442
OTO - NOTNLM
OT  - Cognitive behavior therapy
OT  - Depression
OT  - Diabetes distress
OT  - Health anxiety
OT  - Treatment adherence
OT  - Type 2 diabetes mellitus
COIS- The authors declare that they have no competing interests.
EDAT- 2023/02/05 06:00
MHDA- 2023/02/08 06:00
PMCR- 2023/02/03
CRDT- 2023/02/04 00:05
PHST- 2022/08/01 00:00 [received]
PHST- 2023/01/12 00:00 [accepted]
PHST- 2023/02/04 00:05 [entrez]
PHST- 2023/02/05 06:00 [pubmed]
PHST- 2023/02/08 06:00 [medline]
PHST- 2023/02/03 00:00 [pmc-release]
AID - 10.1186/s12888-023-04546-w [pii]
AID - 4546 [pii]
AID - 10.1186/s12888-023-04546-w [doi]
PST - epublish
SO  - BMC Psychiatry. 2023 Feb 3;23(1):86. doi: 10.1186/s12888-023-04546-w.